By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aurinia (Formerly Known as Isotechnika Pharma Inc.) 

5120 - 75th Street

Edmonton  Alberta  T6E 6W2  Canada
Phone: 780-487-1600 Fax: 780-484-4105


SEARCH JOBS


Key Statistics


Email:
Ownership: Public

Web Site: Aurinia
Employees:
Symbol: AUPH
 









Company News
Aurinia (AUPH) Closes US$173.1 Million Public Offering Of Common Shares And Full Exercise Of Underwriters' Option To Purchase Additional Common Shares 3/21/2017 6:57:54 AM
Aurinia (AUPH) Announces Presentation At 12th International Congress On SLE (LUPUS 2017) & The 7th Asian Congress On Autoimmunity (ACA 2017) 3/17/2017 6:36:11 AM
Aurinia (AUPH) Announces Public Offering Of Common Shares 3/14/2017 6:51:43 AM
Aurinia (AUPH) Prices US$150.5 Million Public Offering Of Common Shares 3/14/2017 6:24:43 AM
Aurinia (AUPH) Reports Fourth Quarter And Full Year 2016 Financial Results And Recent Operational Highlights 3/9/2017 8:22:30 AM
Aurinia (AUPH) Announces Acceptance Of Voclosporin Late-Breaking Presentation At National Kidney Foundation 2017 Spring Clinical Meetings 3/7/2017 8:44:51 AM
Aurinia (AUPH) Announces Acceptance Of Voclosporin Late-Breaking Presentation At National Kidney Foundation 2017 Spring Clinical Meetings 3/7/2017 6:39:09 AM
Why Is Aurinia (AUPH) A Definite Buy In 2017? 3/7/2017 5:42:03 AM
Despite 13 Reported Deaths in 2016, Aurinia (AUPH)'s Lupus Nephritis Drug Shows No New Safety Concerns 3/2/2017 5:38:54 AM
Aurinia (AUPH) Announces Results From Japanese Phase I Ethnic Bridging Study For Voclosporin 2/14/2017 6:13:38 AM
12345678910...
//-->